Kronos Bio Inc (NAS:KRON)
$ 0.94865 -0.06135 (-6.07%) Market Cap: 56.72 Mil Enterprise Value: -63.81 Mil PE Ratio: 0 PB Ratio: 0.41 GF Score: 32/100

Kronos Bio Inc at Evercore ISI HealthCONx Conference (Virtual) Transcript

Dec 01, 2022 / 06:00PM GMT
Release Date Price: $1.84 (-3.16%)
Umer Raffat
Evercore ISI - Analyst

Excellent. Thank you guys for joining us. Pleasure to have Kronos management join us. Many of you may obviously know and remember Norbert over the years discussing many things at Gilead. But today, this is about a new platform and new molecules. So there's a lot to discuss.

Let me turn over to you, Norbert.

Norbert Bischofberger
Kronos Bio, Inc. - President & CEO

Yes. Umer, thank you, and Evercore, for having us. It's a great pleasure to participate in this fireside chat.

Questions & Answers

Umer Raffat
Evercore ISI - Analyst

Outstanding. So Norbert, there's obviously two key programs, and we're going to jump right in. And there's newer stuff which is approaching IND enabling as well. Where do you guys get the most questions? And which one has the first, perhaps, upcoming data readout? Maybe we should start there.

Norbert Bischofberger
Kronos Bio, Inc. - President & CEO

The two programs -- the two

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot